Have questions or comments? Click here.
Last week the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory committee regarding the benefit-to-risk ratio of Long Acting Beta-agonist drugs (LABAs). The advisory panel consisted of 27 voting health care professionals representing subcommittees in pulmonary and allergy medicine, safety and risk, and pediatric advisory.
The medications of interest were LABAs prescribed for treatment... Read moreLast week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory... Read more »
While it has not yet been approved in the United States, Symbicort may some day be available as a rescue inhaler as well as a ... Read more »
So what's the deal with Advair and Symbicort? These meds have helped so many asthmatics finally gain control of their asthma, yet, with... Read more »
Some of the most effective asthma medicines are inhaled steroids, and the downside to this is that the word "steroid" has a bad reputation.... Read more »
While the economy sputters, the long acting bronchodilator/ corticosteroid combination inhaler market is booming. While big ... Read more »